Paralytic Syndromes in Children: Epidemiology and Relationship to Vaccination

Pediatric Neurology

Volumn 42, Issue 3, 2010, Pages 206-212

  Zangwill, Kenneth M ^a   Yeh, Sylvia H ^a   Wong, Emily J ^a   Marcy, S Michael ^a,b   Eriksen, Eileen ^a   Huff, Kenneth R ^c   Lee, Martin ^a   Lewis, Edwin M ^d   Black, Steven B ^e   Ward, Joel I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER PERMANENTE   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d Pediatric Vaccine Study Center   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

ADOLESCENT; ARTICLE; BELL PALSY; BOTULISM; CELLULITIS; CHILD; COHORT ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; DISEASE ASSOCIATION; FACIAL CELLULITIS; FACIAL NERVE PARALYSIS; FLACCID PARALYSIS; GUILLAIN BARRE SYNDROME; HUMAN; INCIDENCE; INFANT; INFECTION RISK; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MYELITIS; MYOSITIS; NEUROMUSCULAR DISEASE; ORGANOPHOSPHATE POISONING; PNEUMOCOCCAL MENINGITIS; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING; STROKE; VACCINATION; VIRUS MENINGITIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; MALE; MENINGOCOCCAL VACCINES; PARALYSIS; POLIOMYELITIS; POLIOVIRUS VACCINE, ORAL; PREVALENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 76249132327     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2009.10.012     Document Type: Article

References (34)

1. Advisory Committee on Immunization Practices, and Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). [Erratum in: MMWR Morb Mortal Wkly Rep 1997;46:183]. MMWR Recomm Rep 46 RR-3 (1997) 1-25
2. Schonberger L.B., Bregman D.J., Sullivan-Bolyai J.Z., et al. Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol 110 (1979) 105-123
3. Centers for Disease Control and Prevention. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine: United States, June 2005-September 2006. [Erratum in: MMWR Morb Mortal Wkly Rep 2006;55:1177]. MMWR Morb Mortal wkly Rep 55 (2006) 1120-1124
4. Kew O.M., Sutter R.W., de Gourville E.M., Dowdle W.R., and Pallansch M.A. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Ann Rev Microbiol 59 (2005) 587-635
5. Alexander L.N., Seward J.F., Santibanez T.A., et al. Vaccine policy changes and epidemiology of poliomyelitis in the United States. JAMA 292 (2004) 1696-1701
6. Nachamkin I., Shadomy S.V., Moran A.P., et al. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccine: insights into vaccine-associated Guillain-Barré syndrome. J Infect Dis 198 (2008) 226-233
7. World Health Organization. Global Polio Eradication Initiative. 2006 Annual Report (2007), WHO Press, Geneva. http://www.polioeradication.org/content/publications/annualreport2006.asp [Available at:
8. Centers for Disease Control and Prevention. Poliovirus infections in four unvaccinated children: Minnesota, August-October 2005. MMWR Morb Mortal Wkly Rep 54 (2005) 1053-1055
9. Centers for Disease Control and Prevention. Imported vaccine-associated paralytic poliomyelitis: United States, 2005. MMWR Morb Mortal Wkly Rep 55 (2006) 97-99
10. Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 49 RR-5 (2000) 1-22
11. Prevots D., Sutter R., Strebel P., Weibel R., and Cochi S. Completeness of reporting for paralytic poliomyelitis, United States, 1980-1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med 148 (1994) 479-485
12. Centers for Disease Control and Prevention. Resurgence of wild poliovirus type 1 transmission and consequences of importation: 21 countries, 2002-2005. MMWR Morb Mortal Wkly Rep 55 (2006) 145-150
13. Chen R.T., DeStefano F., Davis R.L., et al. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. Bull World Health Organ 78 (2000) 186-194
14. DeStefano F. Vaccine Safety Datalink Research Group. The Vaccine Safety Datalink project. Pharmacoepidemiol Drug Saf 10 (2001) 403-406
15. Henderson D.A., Witte J.J., Morris L., and Langmuir A.D. Paralytic disease associated with oral polio vaccines. JAMA 190 (1964) 41-48
16. D'Souza R.M. Retrospective hospital-based searches for cases of acute flaccid paralysis. Aust N Z J Public Health 26 (2002) 45-49
17. Fiore L., Novello F., Simeon P., et al. Afp Study Group. Surveillance of acute flaccid paralysis in Italy: 1996-1997. Eur J Epidemiol 15 (1999) 757-763
18. Morris A.M., Elliott E.J., D'Souza R.M., Antony J., Kennett M., and Longbottom H. Acute flaccid paralysis in Australian children. J Paediatr Child Health 39 (2003) 22-26
19. Oostvogel P.M., Spaendonck M.A., Hirasing R.A., and van Loon A.M. Surveillance of acute flaccid paralysis in the Netherlands, 1992-94. Bull World Health Organ 76 (1998) 55-62
20. Arnon S.S., Schechter R., Maslanka S.E., Jewell N.P., and Hatheway C.L. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med 354 (2006) 462-471
21. Orloski K.A., Hayes E.B., Campbell G.L., and Dennis D.T. Surveillance for Lyme disease: United States, 1992-1998. MMWR CDC Surveill Summ 49 (2000) 1-11
22. World Health Organization. Acute flaccid paralysis (AFP) surveillance. the surveillance strategy for poliomyelitis eradication. Wkly Epidemiol Rec 73 (1998) 113-120
23. Marx A., Glass J.D., and Sutter R.W. Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol Rev 22 (2000) 298-316
24. de Quadros C.A., Hersh B.S., Olivé J.M., Andrus J.K., da Silveira C.M., and Carrasco P.A. Eradication of wild poliovirus from the Americas: acute flaccid paralysis surveillance, 1988-1995. J Infect Dis 175 Suppl. 1 (1997) S37-S42
25. Prevots D.R., and Sutter R.W. Assessment of Guillain-Barré syndrome mortality and morbidity in the United States: implications for acute flaccid paralysis surveillance. J Infect Dis 175 Suppl. 1 (1997) S151-S155
26. Koobatian T.J., Birkhead G.S., Schramm M.M., and Vogt R.L. The use of hospital discharge data for public health surveillance of Guillain-Barré syndrome. Ann Neurol 30 (1991) 619-621
27. Sejvar J.J., Leis A.A., Stokic D.S., et al. Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis 9 (2003) 788-793
28. Grimwood K., Huang Q.S., Sadleir L.G., et al. Acute flaccid paralysis from echovirus type 33 infection. J Clin Microbiol 41 (2003) 2230-2232
29. Chaves S.S., Lobo S., Kennett M., and Black J. Coxsackie virus A24 infection presenting as acute flaccid paralysis. Lancet 357 (2001) 605
30. Strebel P.M., Sutter R.W., Cochi S.L., et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis 14 (1992) 568-579
31. World Health Organization. Global Polio Eradication Initiative: strategic plan 2010-2012. Draft framework document, November 2009 [Available at http://www.polioeradication.org/POW.2010-2012.asp].
32. World Health Organization. Conclusions and recommendations of the Advisory Committee on Poliomyelitis Eradication, Geneva, 27-28 November 2007. Wkly Epidemiol Rec 83 (2008) 25-35
33. De Jesus NH. Epidemics to eradication: the modern history of poliomyelitis. Virol J 4 (2007) 70
34. Chumakov K., Ehrenfeld E., Wimmer E., and Agol V.I. Vaccination against polio should not be stopped. Nat Rev Microbiol 5 (2007) 952-958